CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: IMA-PRESS LLC 2018-05-01
Saila:Научно-практическая ревматология
Gaiak:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Sarrera elektronikoa:https://rsp.mediar-press.net/rsp/article/view/2524
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak